1985
DOI: 10.1093/bja/57.9.883
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of Diazepam and Midazolam When Used for Sedation Following Cardiopulmonary Bypass

Abstract: The water-soluble benzodiazepine, midazolam, was compared with diazepam for postoperative sedation in patients following cardiopulmonary bypass. Midazolam in repeated doses produced a stable plasma concentration within 4 h, showed no tendency to cumulation and was cleared rapidly following discontinuation. Similar doses of diazepam given with the same frequency produced plasma concentrations which were still increasing at the time of discontinuation and which were still greater than their baseline values 24 h … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1986
1986
1995
1995

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…Lack of cumulation with intermittent bolus administration has been reported in a group of adult patients following cardiac surgery (Lowry et aL, 1985). If the clearance values in paediatric patients were similar to those previously measured in adults (Klotz and Reimann, 1984), plasma concentrations of between 200 and 850 ng ml" 1 would be expected from the infusion rates used in these children.…”
Section: Discussionmentioning
confidence: 62%
“…Lack of cumulation with intermittent bolus administration has been reported in a group of adult patients following cardiac surgery (Lowry et aL, 1985). If the clearance values in paediatric patients were similar to those previously measured in adults (Klotz and Reimann, 1984), plasma concentrations of between 200 and 850 ng ml" 1 would be expected from the infusion rates used in these children.…”
Section: Discussionmentioning
confidence: 62%
“…212 Propofol reduces CMR02 and CBF in a dose-dependent manner without affecting cerebral autoregulation. 215 cause of these cerebral effects and other desirable pharmacokinetic and pharmodynamic characteristics of propofol, several studies have assessed the potential of propofol to provide cerebroprotection during ischemia. 215 cause of these cerebral effects and other desirable pharmacokinetic and pharmodynamic characteristics of propofol, several studies have assessed the potential of propofol to provide cerebroprotection during ischemia.…”
Section: Propojolmentioning
confidence: 99%